Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Total Debt / EBITDA

Alexion Pharm Inc Total Debt / EBITDA Chart (ALXN)

Alexion Pharm Inc annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Alexion Pharm Inc Total Debt / EBITDA for the quarter ending June 06, 2020 was $1m a -22.58% decrease of 0m year over year
  • Alexion Pharm Inc Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $1m a -23.10% decrease of 0m year over year
  • Alexion Pharm Inc Annual Total Debt / EBITDA for 2019 was $1m a -43.93% decrease of 0m from 2018
  • Alexion Pharm Inc Annual Total Debt / EBITDA for 2018 was $2m a -38.18% decrease of -1m from 2017
  • Alexion Pharm Inc Annual Total Debt / EBITDA for 2017 was $2m a -26.48% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN Total Debt / EBITDA Data

06/2020$1m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$2m
09/2018$1m
06/2018$2m
03/2018$2m

Annual ALXN Total Debt / EBITDA Data

2019$1m
2018$2m
2017$2m
2016$3m
2015$4m
2014$0m
2013$0m
2012$0m
2010$0m